SANTEN PHARMACEUTICAL CO.,LTD.JP:4536

Market cap
¥636.6B
P/E ratio
34.1x
Mar 31,
2013
Mar 31,
2014
Mar 31,
2015
Mar 31,
2016
Mar 31,
2017
Mar 31,
2018
Mar 31,
2019
Mar 31,
2020
Mar 31,
2021
Mar 31,
2023
Mar 31,
2024
Net sales119,066148,663-------196,589195,238
Cost of sales41,50158,10456,37372,82974,966----87,41592,062
Gross profit (loss)77,56490,558105,458122,463124,130----109,174103,176
Selling, general and administrative expenses52,88363,144-------84,37675,164
Operating profit (loss)24,68127,414-------24,79828,013
Interest and dividend income---------499536
Dividend income of life insurance157147-------155157
Gain on valuation of derivatives---------52232
Income of usage charge---------1,7423,196
Other235225-------152156
Non-operating income1,007975-------2,6004,279
Interest expenses65-------100222
Foreign exchange losses-222-------39248
Commission for purchase of treasury shares25--------7329
Litigation expenses---------51410
Cancellation penalty---------45-
Other5418-------21110
Non-operating expenses86465-------3301,019
Ordinary profit (loss)25,60227,924-------27,06831,272
Gain on disposal of non-current assets17--------32
Gain on sale of investment securities-473-------1,5991,912
Extraordinary income17473-------1,6021,915
Loss on disposal of non-current assets2627-------2324
Impairment losses-94-------747-
Loss on disaster----------755
Loss on valuation of shares of subsidiaries and associates---------77,779-
Provision of allowance for doubtful accounts for subsidiaries and associates----------1,997
Business restructuring expenses----------4,609
Extraordinary losses281,504-------78,5497,384
Profit before income taxes25,59126,893--------49,87925,803
Income taxes - current7,90811,762-------6,3976,529
Income taxes for prior periods---------2,632-
Income taxes - deferred1,162-1,978-------471595
Income taxes9,0709,783-------9,5017,123
Profit (loss)--24,03253,37323,054-----59,37918,680